F10 and heart disorder: NOACs could specifically block certain coagulation factors (such as dabigatran for thrombin or rivaroxaban for factor Xa), thereby inhibiting the conversion of fibrinogen to fibrin, and have been proven to be as efficacious as warfarin for anticoagulation in some cardiac diseases, such as atrial fibrillation [30, 31].